maternal health – Medxy AI

Spontaneous Preterm Birth as a Sentinel for Cardiovascular Mortality: Insights from a National Registry Study

By MedXY 06/04/2026

A large-scale Dutch cohort study reveals that women with a history of spontaneous preterm birth face a significantly elevated risk of cardiovascular mortality, with the highest risk observed in those delivering before 32 weeks of gestation.

Clinical Updates news

Optimizing Gestational Weight Gain in Type 2 Diabetes: Clinical Evidence for Restricted Targets and Perinatal Benefits

By MedXY 05/31/2026

This review synthesizes recent evidence suggesting that weight gain <5 kg in pregnant individuals with type 2 diabetes significantly reduces risks of LGA, hypertensive disorders, and NICU admissions without increasing SGA rates.

news OB/GYN & Women’s Health Public Health

Association Between Racial Segregation of Labor and Delivery Services and Use of Trial of Labor and Vaginal Birth After Cesarean

By MedXY 05/20/2026

Hospitals that serve more Black patients had higher rates of trial of labor after cesarean and VBAC success among low-risk patients, suggesting hospital practices may influence cesarean-related disparities.

news OB/GYN & Women’s Health Psychiatry

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial

By MedXY 05/11/2026

A clinical trial found that weekly extended-release buprenorphine significantly improves illicit opioid abstinence during pregnancy compared to sublingual forms, with fewer serious adverse events, offering a safer treatment option for opioid use disorder.

Neurology news OB/GYN & Women’s Health

Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population-Based Cohort Study

By MedXY 05/04/2026

Canadian research reveals individuals with cerebral palsy face significantly higher risks of severe maternal complications, preterm birth, and neonatal issues during pregnancy, highlighting the need for specialized perinatal care.

news Public Health

Hemorrhage, Hypertensive Disorders, and Infection Are the Leading Underlying Causes of Severe Maternal Morbidity, Study Finds

By MedXY 04/23/2026

A new hierarchical algorithm identifies hemorrhage, hypertensive disorders, and infection as the most common underlying conditions for severe maternal morbidity, differing significantly from causes of maternal mortality.

news Psychiatry

Untreated Maternal Depression Linked to Increased Outpatient Opioid Use Following Cesarean Delivery

By MedXY 03/23/2026

A large multicenter study finds that while maternal depression does not affect inpatient opioid use after cesarean delivery, untreated depression significantly increases outpatient opioid consumption and perceived pain interference during the postpartum recovery period.

Cardiology news

Mechanical Heart Valves in Pregnancy: Navigating the High Risk of Thrombosis and the Biological Valve Advantage

By MedXY 03/20/2026

The ESC EORP ROPAC III registry highlights a stark contrast in pregnancy outcomes between mechanical and biological heart valves, revealing that only 54% of women with mechanical valves achieve an uncomplicated live birth, largely due to anticoagulation-related complications.

Diabetes & Endocrinology news

Maternal Glycemic Control in Gestational Diabetes and Its Impact on Childhood Obesity

By MedXY 03/11/2026

Research indicates that achieving stable and optimal blood sugar levels immediately after a gestational diabetes diagnosis can reduce a child's risk of obesity to levels comparable to those born to mothers without the condition.

Cardiology Clinical Updates news

Clinical Factors and Biomarkers During Pregnancy and Risk of Cardiovascular Disease: Leveraging the ‘Natural Stress Test’

By MedXY 03/10/2026

This review synthesizes findings on how pregnancy biomarkers, particularly sFlt-1 and hs-cTnI, serve as early indicators of long-term maternal cardiovascular risk, offering a unique window for sex-specific prevention.

news Psychiatry

Enhanced Care, Regardless of Format, Reduces Postpartum Depression in High-Risk Populations: Insights from the EMBRACE Trial

By MedXY 02/23/2026

The EMBRACE randomized clinical trial demonstrates that both enhanced group and enhanced individual prenatal care significantly reduce postpartum depressive symptoms in low-income, diverse populations, suggesting that addressing social determinants of health is more critical than the specific delivery format of care.

Cardiology news OB/GYN & Women's Health

Pregnancy as a Window to Longevity: Maternal Biomarkers at 29 Weeks Predict Long-Term Cardiovascular Risk

By MedXY 02/20/2026

A Danish cohort study demonstrates that specific pregnancy biomarkers, particularly sFlt-1 and hs-cTnI measured at 29 weeks, significantly enhance the prediction of long-term cardiovascular disease risk in women, independent of traditional clinical factors and hypertensive disorders of pregnancy.

news

Dapivirine Vaginal Ring and Oral PrEP Confirmed Safe for Use During Second Trimester: Insights from the DELIVER Trial

By MedXY 02/14/2026

The Phase 3b DELIVER trial confirms that both the dapivirine vaginal ring and oral PrEP are safe and well-tolerated when initiated in the second trimester of pregnancy, showing no product-related serious adverse events and high rates of term births.

news Pediatrics

Dose-Response Risk: How Multiple Maternal Chronic Conditions Shape Neonatal Morbidity and Mortality

By MedXY 02/12/2026

This population-based cohort study of over 1 million births reveals that maternal multiple chronic conditions (MCC) significantly increase the risk of severe neonatal morbidity and mortality, with risks escalating alongside the number, complexity, and severity of maternal conditions.

news Public Health

The Growing Challenge of Preeclampsia: Evaluating the USPSTF Screening Model

By MedXY 02/11/2026

This article examines a comprehensive study on the effectiveness of the USPSTF preeclampsia risk assessment guidelines and the implementation of aspirin prophylaxis in modern obstetric care.

news Psychiatry

Prenatal Maternal Depression as a Critical Developmental Risk Factor: Large-Scale IPD Meta-Analysis of 76,514 Children

By MedXY 02/07/2026

This large-scale individual participant data meta-analysis of 76,514 children reveals that prenatal maternal depression is significantly associated with increased risks of ADHD, ASD, and behavioral symptoms, independent of pre-pregnancy depression and largely consistent across both male and female offspring.

AI Diabetes & Endocrinology news

Mobile Health Management Model Slashes Gestational Diabetes Incidence by Nearly 45% in High-Risk Pregnancies

By MedXY 01/10/2026

A randomized controlled trial demonstrates that an mHealth management model using the Better Pregnancy app significantly reduces GDM incidence, improves glycemic control, and enhances maternal self-efficacy among high-risk pregnant women, providing a scalable solution for modern obstetric care.

news OB/GYN & Women's Health

Scheduled Early-Term Birth: A Proven Strategy to Prevent Pre-eclampsia in High-Risk Pregnancies

By MedXY 01/08/2026

The PREVENT-PE trial demonstrates that risk-stratified scheduled birth at 37–38 weeks reduces pre-eclampsia incidence by 30% without increasing neonatal morbidity or emergency cesarean sections, offering a new standard for late-pregnancy management.

Cardiology news

Beyond the Diastolic Threshold: Isolated Severe Systolic Hypertension as a Potent Predictor of Maternal Risk

By MedXY 12/25/2025

A large-scale analysis of over 115,000 patients demonstrates that isolated severe systolic hypertension (SBP ≥160 mmHg) during delivery admission is independently associated with a dramatic, dose-dependent increase in severe maternal morbidity, including pulmonary edema and renal failure.

Cardiology news OB/GYN & Women's Health

Maternal Pre-existing Atherosclerotic Cardiovascular Disease: A Hidden Risk Factor for Neonatal Health and Long-term Neurodevelopment

By MedXY 12/25/2025

A nationwide cohort study demonstrates that maternal pre-existing ASCVD is independently associated with an increased risk of neonatal complications and long-term neurodevelopmental disorders, persisting regardless of adverse pregnancy outcomes.